Improving cancer immunotherapy through microbiome research
FMIP COBRE Administrative Core
This study is looking at how the bacteria in our bodies might affect how well cancer treatments work, especially those that help the immune system fight cancer, and it's designed to help improve treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11038011 on NIH RePORTER |
What this research studies
This research focuses on understanding how the human microbiome interacts with inflammatory responses and disease outcomes, particularly in the context of cancer immunotherapy. The project is led by a multidisciplinary team at the University of Louisville, which aims to enhance administrative efficiency and scientific oversight for ongoing research initiatives. By fostering collaborations and mentoring within the research community, the program seeks to improve the effectiveness of cancer treatments and patient outcomes. Patients may benefit from advancements in immunotherapy strategies that are informed by microbiome research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are patients undergoing cancer treatment, particularly those receiving immunotherapy.
Not a fit: Patients with non-cancerous conditions or those not receiving immunotherapy may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapy treatments tailored to individual patients based on their microbiome.
How similar studies have performed: Other research has shown promising results in the relationship between the microbiome and cancer treatment outcomes, indicating that this approach has potential for significant advancements.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Lamont, Richard J — University of Louisville
- Study coordinator: Lamont, Richard J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.